Pre-Approval Access to Golimumab Subcutaneous for the Treatment of Stage 3 Type-1 Diabetes Mellitus in Children and Young Adults

Name: Pre-Approval Access to Golimumab Subcutaneous for the Treatment of Stage 3 Type-1 Diabetes Mellitus in Children and Young Adults
License: Public Domain

Janssen Research & Development, LLC

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes mellitus, type 1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 300377
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.